Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study

Author(s):
Reinders, M.E.J. (0000-0001-9543-567X); Dreyer, G.J.; Bank, J.R.; Roelofs, H.; Heidt, S. (0000-0002-6700-188X); Roelen, D.L.; Zandvliet, M.L.; Huurman, V.A.L.; Fibbe, W.E. (0000-0001-8539-9011); Kooten, C. van (0000-0002-6257-0899); Claas, F.H.J. (0000-0003-4157-6201); Rabelink, T.J.; Fijter, J.W. de
Published
2015
Publication type
Article / Letter to editor
Allogeneic mesenchymal stromal cellsRenal transplantationImmune responseRejection
Date issued
2015-11-04
Language
English
Is part of
Journal of Translational Medicine
hdl
1887/108040
doi
10.1186/s12967-015-0700-0